Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...

Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation.

He has also said he will soon declare tariffs on the pharma industry, which have been exempt from past trade wars, following his measures against other sectors. The four sources, who asked not to ...

Eisai (TYO: 4523) and Biogen (Nasdaq: BIIB) today provided an update on the ongoing regulatory review of the Marketing ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

He has also said he will soon declare tariffs on the pharma industry, which have been exempt ... drugmakers said it would not be a very lengthy process for it to increase manufacturing of ...

Liberation Day’ tariffs wipe $3.1 trillion from Wall Street as analysts predict global recession - President Trump says his ...

The pharma industry is often thought of as one that ... and consume high amounts of energy in the manufacturing process. When this is combined with a high-volume, low-margin business model ...

An analysis by ING Bank suggests that proposed tariffs could increase the cost of certain cancer treatments by up to $10,000 ...

Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception ... API production facilities, the process would be extremely expensive and ...

German contract development and manufacturing specialist ProBioGen has named Alfred Merz as its new chief executive. He had ...

Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage ...